7 results
10-K
2023 FY
EX-21
FTRE
Fortrea Holdings Inc
13 Mar 24
Annual report
4:39pm
Fortrea Chile Limitada
Chile
Active
Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Chengdu Branch
China
Active
Fortrea … Pharmaceutical Research & Development (Beijing) Co Ltd, Nanjing Branch
China
Active
Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Shanghai Branch
8-K
EX-99.1
FTRE
Fortrea Holdings Inc
3 Jul 23
Entry into a Material Definitive Agreement
4:05pm
companies are projected to increase research and development (“R&D”) investment, grow their pipelines, and outsource more programs to CROs. We believe … on our board of directors because of his extensive experience in the life sciences industry and his expertise in research and development. Dr. Ray
10-12B/A
EX-99.1
FTRE
Fortrea Holdings Inc
8 Jun 23
Registration of securities (amended)
10:33am
research and development (“R&D”) investment, grow their pipelines, and outsource more programs to CROs. We believe these underlying market trends represent … of his extensive experience in the life sciences industry and his expertise in research and development. Dr. Ray will serve on our Audit Committee
10-12B/A
EX-99.1
FTRE
Fortrea Holdings Inc
2 Jun 23
Registration of securities (amended)
5:07pm
the next several years, pharmaceutical and biotechnology companies are projected to increase research and development (“R&D”) investment, grow … expertise in research and development. Dr. Ray will serve on our Audit Committee and our Nominating, Corporate Governance and Compliance Committee.
Betty
10-12B
EX-10.6
FTRE
Fortrea Holdings Inc
15 May 23
Registration of securities
3:20pm
, processes or combinations or applications thereof developed in, by, or for the Company’s business, research and development projects, data, business
10-12B
EX-99.1
9c7izg743 hj
15 May 23
Registration of securities
3:20pm
DRS/A
EX-99.1
mqzo0 suw5pwz
5 Apr 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next